orphan drugs

基本解释

EU-wide harmonisation in the context of accessibility processes and price policies will reduce delays in the availability of orphan drugs.
全欧盟范围内统一的无障碍进程和价格政策将减少延误可用性孤儿药。
The European orphan diseases market grapples with numerous challenges. Of these, the most serious are the lack of awareness, poor diagnosis and limited accessibility of orphan drugs.
欧洲孤儿疾病市场存在许多问题。其中，最严重的是缺乏认识，不良的诊断和有限利用孤儿药物。
EU healthcare ministers should encourage frequent discussions with patients, patient support groups and industry representatives to ensure a transparent and rapid approval process for orphan drugs.
欧盟卫生部长会议鼓励要经常性的与患者，患者支持团体和业界代表进行沟通，以确保透明和快速审批程序孤儿药物。

But before 1983, there were just 38 orphan drugs approved for use in the United States.
FORBES: The Lifesaving Promise Of The Pharmaceutical Drug Pipeline
Insurers may want to avoid negative publicity and will pay for orphan drugs, assuming patient populations remain small.
FORBES: Connect
New orphan drugs are just one of the reasons that individuals with hard-to-treat diseases have reason to hope.
FORBES: The Lifesaving Promise Of The Pharmaceutical Drug Pipeline

罕用药
It is very necessary for the government to intervene to improve the accessibility of orphan drugs.2.
因此,在市场经济条件下,要促进患者罕用药的可及性,政府干预必不可少。